Search - tctmd.com

Displaying 1 - 20 of 160

Sort: Relevancy | Date

AEGIS-I Trial: The Safety and Tolerability of CSL112

Presentation AHA 2016

The Safety and Tolerability of CSL112, a Reconstituted, Infusible, Plasma-Derived Human ApoA-I, After Acute Myocardial Infarction: The ApoA-I Event reducingG in Ischemic Syndromes I Trial (AEGIS-I)

Presenter: Michael Gibson

November 15, 2016

Presentation TCT 2016

Delivery System and Therapeutic Challenges and Opportunities in Africa

Presenter: Graham A. Cassel, Harun A Otieno

November 01, 2016

Presentation TCT 2016

Hot Topic #3: Anti-ischemic Therapy: Beta Blockers, ACE Inhibitors, and Ranolazine - Are They Effective?

Presenter: Bernard J. Gersh, Felix Mahfoud, Ori Ben-Yehuda

November 01, 2016

Presentation TCT 2016

Trial #7 - The Essentials ofCTSN SMR Trial - Two-Year Outcomes Following Mitral Valve Repair or Replacement for Severe Ischemic Mitral Regurgitation

Presenter: William A. Gray, Stephan Windecker, Michael Argenziano

October 31, 2016

Presentation TCT 2016

TCT 94: Impact of Thin-Cap Fibroatheromas on Unanticipated Ischemic Events in Medically Treated Patients With Diabetes Mellitus: Insights From the PROSPECT Study

Presenter: Farouc Jaffer, Amir Lerman, Elvin Kedhi

October 31, 2016

Presentation TCT 2016

Role of Papillary Muscle Relocation in Ischemic Mitral Valve Regurgitation

Presenter: Michael J. Mack, Francesco Maisano, Marco Moscarelli

October 30, 2016

Presentation TCT 2016

A Case Series of Ischemic and Nonischemic Leg Ulcers

Presenter: Koen Deloose, Jihad A. Mustapha, Ethan C Korngold

October 30, 2016

Presentation TCT 2016

LV Volume Reduction in Post-AMI, Ischemic Heart Failure Patients

Presenter: Oscar A. Mendiz, Giora Weisz, Horst Sievert

October 30, 2016

Presentation ESC 2016

Safety and Preliminary Efficacy of Intravenous Allogeneic Mesenchymal Stem Cells in Patients With Non-ischemic Heart Failure

Presenter: Javed Butler

August 28, 2016

Presentation ESC 2016

ANTARCTIC: Assessment of a Normal vs Tailored Dose of Prasugrel After Stenting in 75 yo Patients to Reduce the Composite of Bleeding, Stent Thrombosis and Ischemic Complications

Presenter: Gilles Montalescot

August 28, 2016

Presentation ESC 2016

Feasibility and Safety of Direct Catheter - Based Thrombectomy in the Treatment of Acute Ischemic Stroke: Prospective Registry PRAGUE-16

Presenter: Petr Widimsky

August 27, 2016

Presentation

The Impact of Timing of Ischemic and Hemorrhagic Events on Mortality After PCI: The ADAPT-DES Study

Presenter: Sorin Brener

July 05, 2016

Presentation

Impact of Thin-Cap Fibroatheromas on Unanticipated Ischemic Events in Medically-Treated Diabetics

Presenter: Elvin Kedhi

July 05, 2016

Presentation

Trends in Acute Ischemic Stroke Hospitalizations in the United States

Presenter: Lucas Ramirez

May 11, 2016

Presentation Fellows 2016

Antithrombin Pharmacology for the Interventionalist

Presenter: Jeffrey W. Moses, David J. Cohen

April 16, 2016

Presentation Fellows 2016

Rationale for Revascularization in Stable Ischemic Heart Disease

Presenter: Ajay Kirtane

April 15, 2016

Presentation Intravascular Coronary Imaging and Physiology 2016

CT Imaging in Ischemic Heart Disease: CTA, CT-FFR, and CT-Perfusion – Current Uses and Future Projections

Presenter: Nathaniel Reichek

March 10, 2016

Presentation JIM 2016

Medical therapy optimization with new anti-ischemic drugs

Presenter: Giuseppe Musumeci

February 11, 2016

Presentation

Stent Retrievers for Treating Acute Ischemic Stroke

Presenter: Lahoud Touma

January 28, 2016

Presentation

Mechanical Thrombectomy for Acute Ischemic Stroke: a Meta-analysis of Randomized Trials

Presenter: IY. Elgendy

November 30, 2015

Advertisement

The Safety and Tolerability of CSL112, a Reconstituted, Infusible, Plasma-Derived Human ApoA-I, After Acute Myocardial Infarction: The ApoA-I Event reducingG in Ischemic Syndromes I Trial (AEGIS-I)

Delivery System and Therapeutic Challenges and Opportunities in Africa

Hot Topic #3: Anti-ischemic Therapy: Beta Blockers, ACE Inhibitors, and Ranolazine - Are They Effective?

Trial #7 - The Essentials ofCTSN SMR Trial - Two-Year Outcomes Following Mitral Valve Repair or Replacement for Severe Ischemic Mitral Regurgitation

TCT 94: Impact of Thin-Cap Fibroatheromas on Unanticipated Ischemic Events in Medically Treated Patients With Diabetes Mellitus: Insights From the PROSPECT Study

Role of Papillary Muscle Relocation in Ischemic Mitral Valve Regurgitation

A Case Series of Ischemic and Nonischemic Leg Ulcers

LV Volume Reduction in Post-AMI, Ischemic Heart Failure Patients

Safety and Preliminary Efficacy of Intravenous Allogeneic Mesenchymal Stem Cells in Patients With Non-ischemic Heart Failure

ANTARCTIC: Assessment of a Normal vs Tailored Dose of Prasugrel After Stenting in 75 yo Patients to Reduce the Composite of Bleeding, Stent Thrombosis and Ischemic Complications

Feasibility and Safety of Direct Catheter - Based Thrombectomy in the Treatment of Acute Ischemic Stroke: Prospective Registry PRAGUE-16

The Impact of Timing of Ischemic and Hemorrhagic Events on Mortality After PCI: The ADAPT-DES Study

Impact of Thin-Cap Fibroatheromas on Unanticipated Ischemic Events in Medically-Treated Diabetics

Trends in Acute Ischemic Stroke Hospitalizations in the United States

Antithrombin Pharmacology for the Interventionalist

Rationale for Revascularization in Stable Ischemic Heart Disease

CT Imaging in Ischemic Heart Disease: CTA, CT-FFR, and CT-Perfusion – Current Uses and Future Projections

Medical therapy optimization with new anti-ischemic drugs

Stent Retrievers for Treating Acute Ischemic Stroke

Mechanical Thrombectomy for Acute Ischemic Stroke: a Meta-analysis of Randomized Trials

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content